The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 250 movers: De La Rue climbs on profit, broker comment

Wed, 28th May 2014 14:00

Banknote printer De La Rue rose after it posted a 43% jump in full-year underlying operating profit and said it has entered the new financial year with a good order book. Helping it higher was Investec, which upped its target price from 890p to 915p and left its 'buy' recommendation unaltered.Also on the rise was Serco, which has been selected to manage the new 15-year franchise for the Caledonian Sleeper service between London and several Scottish cities. From April 1st 2015, the company will take over from FirstGroup which currently operates the service through its ScotRail franchise.Despite the news, FirstGroup remained in positive territory, up around 0.3%. Infrastructure specialist Balfour Beatty was higher on the news it has won a further framework contract with Heathrow Airport worth between £180m over three years. The group, which could see the framework increased by £70m over a further two years from 2016, will work with Heathrow to maintain and upgrade Terminals 1, 2 and 4.Hikma Pharmaceuticals was also in positive territory, having agreed to acquire certain key assets of the Bedford Laboratories generic injectables business from US-based Ben Venue Laboratories for up to $300m. The purchase will be made for an initial $225m upfront cash payment as well as up to a further $75m in contingent cash payments during the following five-year period.Meanwhile, Cable & Wireless Communications fell sharply, which may be linked to reports it is planning to up its investment in its Caribbean and Central American networks. According to various reports, the group is planning to invest more than $1bn in the next three years on fixed and mobile networks. FTSE 250 - RisersDe La Rue (DLAR) 883.00p +9.01%Ocado Group (OCDO) 368.70p +6.99%Kazakhmys (KAZ) 276.00p +4.15%Lancashire Holdings Limited (LRE) 639.50p +3.81%Laird (LRD) 296.00p +3.75%Vedanta Resources (VED) 1,101.00p +3.57%RPS Group (RPS) 298.40p +3.54%SIG (SHI) 192.50p +3.49%Serco Group (SRP) 367.20p +3.44%UBM (UBM) 689.00p +3.14%FTSE 250 - FallersBwin.party Digital Entertainment (BPTY) 117.40p -3.22%Cable & Wireless Communications (CWC) 53.80p -3.06%Amec (AMEC) 1,171.00p -2.82%Rightmove (RMV) 2,279.00p -2.61%Marston's (MARS) 150.50p -2.53%Aveva Group (AVV) 2,299.00p -2.17%Inchcape (INCH) 624.50p -2.04%Barr (A.G.) (BAG) 626.50p -1.96%Fidessa Group (FDSA) 2,249.00p -1.88%Bellway (BWY) 1,378.00p -1.64%NR
More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.